局所進行胃癌に対する術前化学放射線療法の実現可能性試験

基本情報

NCT ID

NCT01381913

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

12

治験依頼者名

Kagawa University

概要

Because locally far-advanced gastric cancer combined with adjacent tissue invasion has a poor prognosis, some phase 2 and 3 clinical trials of neoadjuvant chemotherapy (NAC) are performed in Japan. However, neoadjuvant chemoradiotherapy (NACRT) achieves superior local tumor control compared with NAC. This feasibility trial explored the feasibility and safety of neoadjuvant chemoradiotherapy (NACRT) in this type of gastric cancer.

対象疾患

依頼者（Sponsor）

実施施設 (1)